Modernizing EQUITY TAX CREDITS in Atlantic Canada

Bionova advocates for Economic Growth

BioFuture 2030

We’ve launched BioFuture 2030
An Economic Growth Plan for Nova Scotia’s Health and Life Sciences Sector

International BioPartnering Program

Learn more about the International BioPartnering Program

Latest News

ENTREVESTOR: IMV Inc. entering a crucial phase in late 2019

Read original article here IMV Inc., the Dartmouth company developing a delivery platform for immunotherapy drugs, is entering a critical ...
Read More

NEWS

ENTREVESTOR: IMV Inc. entering a crucial phase in late 2019

Read original article here IMV Inc., the Dartmouth company developing a delivery platform for immunotherapy drugs, is entering a critical phase of its 16-year history as it will soon learn the results of key Phase 2 clinical trials. The company is conducting a range...

Entrevestor: Motryx Wins $100K Women’s Fund Grant

Read full ENTREVESTOR article here Halifax-based Motryx, which produces sensors that monitor the storage conditions of blood samples during transport, has been awarded a $97,500 grant from the federally funded Women Entrepreneurship Strategy. CEO Franziska Broell, who...

EVENTS

No event found!

SOCIAL


Don’t miss our panel session on The Future of Personalized Health & Human Performance featuring Travis McDonough from @Kinduct discussing his work with @NSHAResearch on improving orthopaedic diagnostics and more https://t.co/AYF7adKEfh

It takes many years for pharmaceutical companies to bring their drugs to market and we want to congratulate our members @imv_inc on their Phase 2 clinical trial. Their drug may prolong the lives of people suffering with hard-to-treat forms of cancer. #LifeSciences https://t.co/BCFtQJTVud
BioNovaNS photo
Entrevestor @entrevestor
Dartmouth-based IMV Inc., developing a delivery platform for #immunotherapy drugs, is entering a critical phase of its 16-year history as it will soon learn the results of key Phase 2 clinical trials. https://t.co/dMdaP4dgZB https://t.co/u9R01lxOmU

ABOUT BIONOVA

Our mandate is to:

  • LEAD the development of Health and Life Science in Nova Scotia
  • ACCELERATE companies and the business ecosystem
  • ADVOCATE for the sector and growth of Nova Scotia’s BioEconomy

OUR SECTOR STRENGTHS

  • Medical Technologies
  • Digital Health
  • Pharmaceuticals & Vaccines
  • Natural Health Products
  • BioProducts

Please visit our Sector Strengths page to learn more.

OUR ACCELERATION INITIATIVES

BioNova aims to accelerate the innovation and productivity of businesses in Nova Scotia’s bioeconomy through our Projects, Programs, Services & Events with the support of our stakeholders and funding partners.